missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CNPY2/MSAP Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech
  7. 16853374

CNPY2/MSAP Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech

Rabbit Polyclonal Antibody

Brand:  Proteintech 14635-1-AP-150UL

 View more versions of this product

Product Code. 16853374

  • 4652.90 SEK / 150µL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

This antibody is specific to CNPY2.

CNPY2 is positive regulator of neurite outgrowth by stabilizing myosin regulatory light chain (MRLC). It prevents MIR-mediated MRLC ubiquitination and its subsequent proteasomal degradation.
Specifications

Specifications

CNPY2/MSAP
Polyclonal
Unconjugated
CNPY2
canopy 2 homolog (zebrafish), CNPY2, HP10390, MSAP, Protein canopy homolog 2, TMEM4, Transmembrane protein 4, ZSIG9
Rabbit
Antigen Affinity Chromatography
RUO
10330, 56530, 685814
-20°C
Liquid
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunoprecipitation
0.15 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
Q9QXT0, Q9Y2B0
Cnpy2
CNPY2,MSAP Fusion Protein Ag6214
150 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.